Clovis Oncology
CLVS
#10652
Rank
NZ$20.86 M
Marketcap
NZ$0.14
Share price
0.00%
Change (1 day)
-94.71%
Change (1 year)

Clovis Oncology (CLVS) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : NZ$1.35 Billion

According to Clovis Oncology's latest financial reports the company's total liabilities are NZ$1.35 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Clovis Oncology - Total liabilities on balance sheet (from 2010 to 2022)

Total liabilities by year

Year Total liabilities Change
2021-12-31NZ$1.10 B3.89%
2020-12-31NZ$1.05 B-15.46%
2019-12-31NZ$1.25 B17.21%
2018-12-31NZ$1.06 B106.54%
2017-12-31NZ$0.51 B-2.62%
2016-12-31NZ$0.53 B-11.86%
2015-12-31NZ$0.60 B3.94%
2014-12-31NZ$0.58 B214.18%
2013-12-31NZ$0.18 B1115.48%
2012-12-31NZ$15.19 M1.76%
2011-12-31NZ$14.92 M-85.77%
2010-12-31NZ$0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
NZ$212.15 B 15,555.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$207.73 B 15,228.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$253.57 B 18,610.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$151.31 B 11,065.47%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$118.09 B 8,613.80%๐Ÿ‡ฌ๐Ÿ‡ง UK
BioMarin Pharmaceutical
BMRN
NZ$4.21 B 211.11%๐Ÿ‡บ๐Ÿ‡ธ USA